Apollo Endosurgery enrolled the first patient in a multi-center randomized controlled trial endoscopic sleeve gastroplasty using Apollo’s OverStitch Endoscopic Suturing System in patients with ...
Apollo Endosurgery posted a net loss of $8.8 million for the second quarter, despite growing worldwide sales of Overstitch, its endoscopic suturing system, by 40 percent. 1. In the U.S., the company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results